Print Friendly Page
A Pilot Study to Evaluate the Therapeutic Response of Tumor Cells Co-cultured with Non-tumor Cells from Patients with Multiple Myeloma ex vivo
Researchers at the University of Wisconsin in cooperation with Lynx Biosciences would
like to collect an extra sample of your bone marrow (about 1-2 teaspoons) for research
testing to help study the development, progression, and treatment of multiple myeloma.
In this study, you will have an extra sample of bone marrow collected for research at one
time point. The extra research sample will be drawn at the time that you are having your
regular bone marrow biopsy. Your sample will be used for studies to help
investigate multiple myeloma and its treatment.
There are no other study-related procedures after the collection of the bone marrow sample. Often, patients have more than one bone marrow biopsy during the course of their clinical care. If you are scheduled for another clinical bone marrow biopsy, it is possible that you will be invited to participate in this study again at that time. You can choose to only participate one time, or you can give a research sample at every clinical biopsy. If you are invited
to participate again, you would sign a new consent form at that time.
- Presumed or confirmed diagnosis of multiple myeloma, including those with relapsed, refractory, or newly diagnosed disease
- Planning to start chemotherapy within the next 6 weeks
- Willingness to undergo bone marrow aspirate biopsy prior to initiation of next therapy
- Subject is 18 years of age or older
- Patients who are known to be HIV positive or Hepatitis B or C positive are excluded
Applicable Disease Sites
UW Hospital and Clinics